The Food and Drug Administration has revealed that the maker of a brand of eye drops linked to an outbreak of fatal bacterial infections failed to follow multiple safety protocols.
The FDA visited a Global Pharma Healthcare facility in India for an inspection in mid-February and found dozens of issues ranging from dirty equipment and clothing to missing safeguards and procedures.
The inspection came two-and-a-half weeks after the company voluntarily recalled the EzriCare artificial tears product because of possible contamination.
When the recall was issued, there were already 55 reports of adverse events, including eye infections, permanent loss of vision, and at least one death from a bloodstream infection.
Bhavin Shah of ServiceNow discusses how the new Autonomous Workforce AI automates tasks, integrates with Teams and Slack, and boosts workplace efficiency.
Angi is partnering with OpenAI to bring its home services marketplace directly into ChatGPT, allowing users to go from questions to booking local pros.
Tech stocks are rallying on strong earnings and massive AI investment. Investors are watching Nvidia & hyperscaler spending for clues on how long it will last.
